Arthur David J. 4
4 · Salarius Pharmaceuticals, Inc. · Filed Feb 15, 2023
Insider Transaction Report
Form 4
Arthur David J.
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2023-02-13+14,300→ 48,019 total
Holdings
- 564(indirect: By son)
Common Stock
- 552(indirect: By daughter)
Common Stock
Footnotes (1)
- [F1]Restricted stock granted under the Salarius Pharmaceuticals, Inc. 2015 Equity Incentive Plan in lieu of cash for performance bonus. The shares of common stock are subject to a six-month holding period pursuant to the terms of the restricted stock agreement.